b.jankowiak
TL3 Regular · Dundee, UK
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 15 September 2024 · last posted 3d · groups: journal-club
150 posts, newest first. Showing up to 150.
-
Why the cheapest option is often not the cheapest Replied, post #23 · Access › Pricing · 25 Jul 2026 · 0 likes I keep a log for cheapest option specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
-
Seven-day rolling means and why weekly readings mislead Replied, post #103 · Outcomes › Progress reports · 25 Jul 2026 · 21 likes On seven-day rolling the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #120 · Analytics › Home & field testing · 24 Jul 2026 · 23 likes Reading this consumer-accessible tests thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Why the Start Here categories exist, and what they are not for Replied, post #29 · Start Here › Welcome · 23 Jul 2026 · 7 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #56 · Practice › Interactions · 22 Jul 2026 · 29 likes On Delayed gastric emptying and oral, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
What a certificate commits its issuer to Replied, post #77 · Analytics › COA interpretation · 22 Jul 2026 · 4 likes That is clearer than the version I had in my head. Thank you.
-
Aggregate verification data across the directory, with caveats Replied, post #49 · Sourcing › Independent verification · 15 Jul 2026 · 0 likes Post #47 answers the question as asked. The question underneath it is different. The practical version of aggregate verification data is three sentences long. The…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #74 · Analytics › Home & field testing · 12 Jul 2026 · 29 likes The tare problem is the catch with weighing: vial-to-vial glass mass varies, so the useful measurement is the spread across a consignment rather than an absolute…
-
Batch numbers that do not match the vial label Replied, post #38 · Sourcing › Red flags · 4 Jul 2026 · 11 likes The most useful contribution to this subcategory is a resolved case written up with the resolution, because the unresolved ones are all anyone remembers. Two people can…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #54 · Outcomes › Progress reports · 24 Jun 2026 · 0 likes Plateau came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Forced degradation studies: designing one that is informative Replied, post #82 · Analytics › Method validation · 22 Jun 2026 · 11 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
-
Revisiting: What pooling buys you and what it destroys Replied, post #63 · Evidence › Meta-analyses · 21 Jun 2026 · 7 likes The arithmetic on pooling buys is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
A calculator that gives a right answer to the wrong question Replied, post #28 · Data & Tools › Calculators · 17 Jun 2026 · 0 likes On post #24 — agreed on the reasoning, with one qualification. Dead volume is the input most calculators do not have, which is why their answer and the delivered dose…
-
Batch numbers that do not match the vial label Replied, post #27 · Sourcing › Red flags · 10 Jun 2026 · 0 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own. Worth checking against…
-
Spreadsheets: an appreciation — what changed since Replied, post #66 · Lounge › Off topic · 9 Jun 2026 · 13 likes Trying to state the Spreadsheets position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #86 · Evidence › Journal club · 9 Jun 2026 · 0 likes Two sentences on orforglipron phase 2 and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #59 · Practice › Interactions · 7 Jun 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #61 · Practice › Storage & stability · 6 Jun 2026 · 18 likes Post #59 is the version of this I will quote in future. One addition. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
-
Second pass at: Programming during a large energy deficit Replied, post #12 · Nutrition & Training › Resistance training · 3 Jun 2026 · 28 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Programming during a large energy, because it is the sort of…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #26 · Access › Insurance & coverage · 29 May 2026 · 0 likes Post #23 answers the question as asked. The question underneath it is different. The denial letter is the specification for your appeal. It states a criterion, and the…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #20 · Analytics › Method validation · 21 May 2026 · 14 likes Distinguishing three things in the specificity discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #6 · Evidence › Meta-analyses · 15 May 2026 · 0 likes On post #4 — agreed on the reasoning, with one qualification. Fixed-effect and random-effects models answer different questions. The first assumes one true effect; the…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #13 · Analytics › Mass spectrometry · 12 May 2026 · 8 likes The practical version of 2 ppm match is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #102 · Practice › Interactions · 10 May 2026 · 15 likes What I would want before treating Metformin co-administration as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #96 · Research Methods › Statistics · 5 May 2026 · 13 likes Baseline imbalance in a randomised trial is expected by chance and adjusting for it post hoc is a choice that should have been pre-specified. This has been discussed…
-
Spreadsheets: an appreciation — what changed since Replied, post #22 · Lounge › Off topic · 19 Apr 2026 · 5 likes Mildly off-topic appreciation: whoever maintains the storage-conditions document has kept it current through three revisions without ever overstating what the…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #61 · Data & Tools › Calculators · 14 Apr 2026 · 0 likes Nothing to add, except that this is the answer I would give if asked.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #30 · Evidence › Journal club · 13 Apr 2026 · 2 likes What I would check first on indirect comparison is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Prediction intervals and why they are more honest than confidence intervals Replied, post #21 · Evidence › Meta-analyses · 9 Apr 2026 · 0 likes Source for the prediction intervals figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #45 · Clinical › Comorbidities · 27 Mar 2026 · 31 likes Narrowing post #44, because the general version has more than one answer. Post-authorisation safety studies are the place where under-studied populations eventually…
-
Run-in periods and the population they select Replied, post #87 · Evidence › Trials · 24 Mar 2026 · 7 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
About the Sleep category Replied, post #6 · Wellbeing › Sleep · 23 Mar 2026 · 25 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
About the How to Ask category Replied, post #11 · Start Here › How to Ask · 17 Mar 2026 · 32 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Preprint servers and what screening they do — the long version Replied, post #6 · Evidence › Preprints · 15 Mar 2026 · 1 like A preprint that has been up for two years without appearing in a journal is telling you something, and it is not necessarily that the work is bad. Where I would look…
-
About the Pens & autoinjectors category Replied, post #6 · Devices › Pens & autoinjectors · 12 Mar 2026 · 25 likes The arithmetic in post #5 is right; the assumption feeding it is the part to check. Some pens indicate remaining doses and some do not, and reading the residual volume…
-
The lowest dose that does anything: is that a real question? Replied, post #59 · Practice › Dosing & titration · 5 Mar 2026 · 27 likes I read post #55 twice before replying, because I had assumed the opposite. Holding at a dose that is working is a legitimate position and it is not what the trial…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #47 · Analytics › Impurities & related substances · 4 Mar 2026 · 7 likes Post #43 and I disagree about the size of the effect, not about the direction. Racemisation produces a diastereomer that is mass-identical and chromatographically…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #8 · Sourcing › Logistics · 28 Feb 2026 · 22 likes Picking up post #5: that is the part I would want checked first. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by…
-
Second pass at: I joined for one answer and stayed for a year — what changed my mind Replied, post #3 · Start Here › Welcome · 27 Feb 2026 · 7 likes Helpful, and short, which on this subject is harder than long.
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #7 · Clinical › Bloodwork · 25 Feb 2026 · 0 likes Since Liver enzymes drifting keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #47 · Practice › Reconstitution · 16 Feb 2026 · 27 likes Nobody has said the unglamorous part of reconstitution volumes yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #26 · Compounds › Other compounds · 16 Feb 2026 · 1 like Picking up post #25: that is the part I would want checked first. Dose conversions between related compounds in this subcategory are made far too casually. Structural…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #23 · Clinical › Bloodwork · 13 Feb 2026 · 2 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #8 · Outcomes › Progress reports · 12 Feb 2026 · 0 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions.
-
Liver enzymes drifting down and what that usually means Replied, post #54 · Clinical › Bloodwork · 7 Feb 2026 · 18 likes Adding the boring version of liver enzymes drifting, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #29 · Evidence › Study critique · 5 Feb 2026 · 5 likes Surrogate endpoints are not automatically bad and their validity is compound-specific and population-specific. The question is whether this surrogate has been validated…
-
What I would record differently if I started again — the long version Replied, post #26 · Outcomes › Progress reports · 5 Feb 2026 · 4 likes Picking up post #25: that is the part I would want checked first. A single scale used throughout beats a more accurate scale introduced halfway through. Consistency…
-
A genuinely late dose: what the labelling says and what people do — what changed since Replied, post #13 · Practice › Administration · 16 Jan 2026 · 12 likes Building on post #12 rather than restating it. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a…
-
Run-in periods and the population they select Replied, post #51 · Evidence › Trials · 16 Jan 2026 · 15 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #11 · Regional › UK & Ireland · 15 Jan 2026 · 21 likes A definition problem is doing most of the work in this pharmacy supply discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is…
-
A partial dose because the pen emptied mid-injection Replied, post #88 · Practice › Administration · 10 Jan 2026 · 0 likes Agreed on all of that, and I have nothing to add to it.
-
A partial dose because the pen emptied mid-injection Replied, post #63 · Practice › Administration · 9 Jan 2026 · 8 likes Summarising the partial dose because the pen thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #49 · Regional › UK & Ireland · 8 Jan 2026 · 0 likes Worth separating two things that post #47 runs together. I keep a log for Private prescribing specifically because my memory of it turned out to be systematically wrong…
-
Journal club: LEADER as the historical anchor Replied, post #18 · Evidence › Journal club · 1 Jan 2026 · 31 likes What I would check first on LEADER is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #36 · Devices › Pens & autoinjectors · 29 Dec 2025 · 0 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
Second pass at: What pooling buys you and what it destroys Replied, post #5 · Evidence › Meta-analyses · 28 Dec 2025 · 0 likes The reason pooling buys keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Appeal templates and why they are deliberately unemotional Replied, post #28 · Access › Insurance & coverage · 24 Dec 2025 · 31 likes One caution on appeal templates: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #23 · Practice › Interactions · 21 Dec 2025 · 24 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #50 · Sourcing › Independent verification · 20 Dec 2025 · 6 likes A note on how interpreting a result gets discussed rather than on interpreting a result itself: the confident posts get the replies and the careful ones get ignored,…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #20 · Practice › Interactions · 18 Dec 2025 · 2 likes This follows post #19 rather than contradicting it. Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more…
-
The decimal-point error, and the habit that catches it Replied, post #66 · Practice › Reconstitution · 16 Dec 2025 · 4 likes Adding the measurement that post #65 says would settle it. Worth separating decimal-point error as a question about the compound from decimal-point error as a question…
-
Documentation that materially improves an appeal's chances Replied, post #97 · Access › Insurance & coverage · 10 Dec 2025 · 0 likes Before the thread moves on from documentation — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four…
-
Persistent vomiting and the threshold for seeking help Replied, post #84 · Safety › Adverse events · 8 Dec 2025 · 25 likes Practical answer on persistent vomiting, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #24 · Compounds › Tirzepatide · 7 Dec 2025 · 5 likes I read post #22 twice before replying, because I had assumed the opposite. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Dead volume across syringe and needle combinations Replied, post #31 · Devices › Syringes & needles · 29 Nov 2025 · 24 likes Post #29 and I disagree about the size of the effect, not about the direction. Needle length for subcutaneous delivery is a question about tissue depth and injection…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #26 · Practice › Reconstitution · 23 Nov 2025 · 0 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #2 · Practice › Storage & stability · 19 Nov 2025 · 7 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. What is reasonably well supported: refrigeration slows…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #7 · Compounds › Tirzepatide · 19 Nov 2025 · 0 likes Adding the measurement that post #6 says would settle it. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #100 · Practice › Reconstitution · 16 Nov 2025 · 0 likes Post #99 is right about the mechanism and I think understates the practical bit. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #15 · Evidence › Trials · 15 Nov 2025 · 6 likes Non-inferiority margins are chosen, and the choice is an argument rather than a fact. A wide margin can make a worse treatment look acceptable.
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #21 · Compounds › Tirzepatide · 8 Nov 2025 · 2 likes Confirming post #20 from a second method, which matters more than confirming it from a second person. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #11 · Practice › Dosing & titration · 5 Nov 2025 · 15 likes A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day…
-
Sleep tracking data and its considerable limitations Replied, post #87 · Wellbeing › Sleep · 25 Oct 2025 · 0 likes My understanding of sleep is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Temperature loggers worth the money — the long version Replied, post #61 · Devices › Cold chain · 22 Oct 2025 · 27 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Payment mechanics and the recovery options that do not exist Replied, post #37 · Sourcing › Payments · 20 Oct 2025 · 19 likes The honest answer on payment mechanics is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.…
-
New subcategory: rationale and scope Replied, post #69 · Meta › Announcements · 20 Oct 2025 · 17 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #48 · Start Here › Welcome · 17 Oct 2025 · 5 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.…
-
Reading an interaction checker output critically Replied, post #23 · Practice › Interactions · 16 Oct 2025 · 32 likes Where I would push back on the reading an interaction checker output consensus is the confidence, not the direction. The direction looks right. The confidence is…
-
Tracking that stops updating and then resumes — the long version Replied, post #25 · Sourcing › Logistics · 13 Oct 2025 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
A preprint whose numbers changed substantially at publication Replied, post #81 · Evidence › Preprints · 6 Oct 2025 · 3 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight. It reads as pedantry until the day it does not.
-
Compounds this community declines to help with, and why Replied, post #65 · Compounds › Other compounds · 5 Oct 2025 · 3 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #12 · Evidence › Preprints · 26 Sep 2025 · 5 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim. Flagging…
-
Compounds this community declines to help with, and why Replied, post #14 · Compounds › Other compounds · 25 Sep 2025 · 0 likes Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #4 · Compounds › Retatrutide · 23 Sep 2025 · 0 likes Worth separating two things that the opening post runs together. Retatrutide is investigational. Material obtained outside a clinical trial is research-use-only by…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #3 · Practice › Storage & stability · 17 Sep 2025 · 0 likes Useful. I have added it to my own notes with the date on it.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #36 · Lounge › Off topic · 14 Sep 2025 · 5 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. Correct me on the arithmetic if it is wrong; I would rather know.
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #47 · Analytics › HPLC & UHPLC · 12 Sep 2025 · 20 likes That is a fair summary of where the discussion has got to.
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #6 · Analytics › Impurities & related substances · 8 Sep 2025 · 16 likes I keep a log for particulates specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
-
Enforcement priorities versus written rules — does this still hold? Replied, post #34 · Sourcing › Regulatory · 28 Aug 2025 · 2 likes Small methodological point on Enforcement priorities: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Pinch or no pinch, and how needle length changes the answer Replied, post #29 · Practice › Administration · 22 Aug 2025 · 0 likes Post #25 describes the usual case. This is about the unusual one. The reason pinch is hard to answer is that the obvious measurement and the relevant quantity are not…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #78 · Evidence › Trials · 22 Aug 2025 · 1 like Taking post #76 at face value and following it one step further. An honest declaration on Sample size calculations: I have a prior here and it is strong enough that you…
-
Are there stupid questions here? A staff answer, at length Replied, post #97 · Start Here › Welcome · 21 Aug 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #82 · Access › Insurance & coverage · 16 Aug 2025 · 0 likes Worth separating two things that post #78 runs together. Adding the boring version of Reading a denial letter, because the interesting version keeps getting posted and…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #24 · Compounds › Tirzepatide · 8 Aug 2025 · 20 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #67 · Access › Insurance & coverage · 4 Aug 2025 · 14 likes Building on post #66 rather than restating it. A peer-to-peer review is available in many systems and is frequently more productive than a written appeal, because it is…
-
Coming back to: When "no data" is the complete and final answer Replied, post #69 · Compounds › Other compounds · 3 Aug 2025 · 0 likes Everything in post #65 holds. The case it does not cover is the one I have. How to research a compound with no human data: mechanistic plausibility is one input.…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #34 · Sourcing › Vendor reports · 2 Aug 2025 · 12 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable.
-
Checking someone else's arithmetic: a worked example thread Replied, post #68 · Practice › Reconstitution · 17 Jul 2025 · 10 likes Post #65 is right about the mechanism and I think understates the practical bit. Preservative effectiveness is tested against a defined microbial challenge under…
-
Antibiotics and a course of something with delayed emptying Replied, post #89 · Practice › Interactions · 13 Jul 2025 · 1 like Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the…
-
How to read a forest plot, properly, from scratch Replied, post #3 · Evidence › Trials · 5 Jul 2025 · 10 likes The opening post put the caveat in the right place and I want to underline it. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #9 · Devices › Pens & autoinjectors · 3 Jul 2025 · 30 likes Picking up post #6: that is the part I would want checked first. Nothing here is medical advice, and pen technique is the single easiest thing to have demonstrated in…
-
A report I filed that turned out to be wrong, and the correction Replied, post #112 · Sourcing › Vendor reports · 20 Jun 2025 · 28 likes I came in to disagree and I am leaving without a disagreement.
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #24 · Compounds › Semaglutide · 11 Jun 2025 · 3 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #27 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2025 · 0 likes Posting my CagriSema phase 2 paper numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #5 · Sourcing › Vendor reports · 24 May 2025 · 17 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Travel coolers and how long they really hold — the long version Replied, post #11 · Devices › Cold chain · 21 May 2025 · 7 likes Travel coolers has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #55 · Practice › Reconstitution · 19 May 2025 · 0 likes Marking my place. If it changes for me I will come back and say so.
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #52 · Wellbeing › Mental health · 16 May 2025 · 3 likes Building on post #51 rather than restating it. History of disordered eating looks different depending on whether you are reading the primary literature or the summaries…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #46 · Compounds › Repair & healing peptides · 16 May 2025 · 27 likes Where I part company with post #44, and it is a narrow parting. Where the BPC-157 reasoning breaks down for me is the step from the group result to the individual case.…
-
A report I filed that turned out to be wrong, and the correction Replied, post #6 · Sourcing › Vendor reports · 6 Apr 2025 · 0 likes This follows post #5 rather than contradicting it. Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #15 · Compounds › Retatrutide · 5 Apr 2025 · 13 likes Post #12 is right about the mechanism and I think understates the practical bit. The question underneath Retatrutide mass and identity is usually "how would I tell?"…
-
Why quantitation is the hard part, not detection Replied, post #8 · Analytics › Home & field testing · 27 Mar 2025 · 11 likes Quantitation is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which…
-
Adjudicated events and why the definition matters — the long version Replied, post #66 · Evidence › Trials · 26 Mar 2025 · 14 likes That is a cleaner way of putting what I was circling around.
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 25 Mar 2025 · 22 likes The arithmetic in post #25 is right; the assumption feeding it is the part to check. Nausea appears in the amylin-analogue literature as it does in the incretin…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 23 Mar 2025 · 13 likes Taking post #14 at face value and following it one step further. Worth distinguishing the combination product from the two components bought separately and mixed. Those…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #31 · Access › Insurance & coverage · 21 Mar 2025 · 4 likes Post #29 put the caveat in the right place and I want to underline it. I keep a log for Coverage specifically because my memory of it turned out to be systematically…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #130 · Sourcing › Vendor reports · 18 Mar 2025 · 22 likes Post #126 put the caveat in the right place and I want to underline it. Include the sample handling: how it was stored, how it travelled to the laboratory, how long it…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #72 · Analytics › Mass spectrometry · 14 Mar 2025 · 26 likes Post #69 answers the question as asked. The question underneath it is different. I changed my mind about oxidation and deamidation mass shifts after someone here asked…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #90 · Pharmacology › Receptor biology · 13 Mar 2025 · 0 likes On post #86 — agreed on the reasoning, with one qualification. Glucagon receptor agonism raises energy expenditure and promotes hepatic fat oxidation. In a triple…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #31 · Analytics › Mass spectrometry · 10 Mar 2025 · 18 likes My experience of adducts contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #27 · Evidence › Journal club · 6 Mar 2025 · 3 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
Charge states for a 4 kDa peptide, worked through Replied, post #5 · Analytics › Mass spectrometry · 1 Mar 2025 · 0 likes Adding the measurement that post #2 says would settle it. The honest summary of what a mass result buys you: it narrows the field of what the material could be,…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #94 · Compounds › Other compounds · 19 Feb 2025 · 0 likes I would be cautious about generalising from the Research-use-only status example above. It is a good example. It is one example.
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #133 · Evidence › Journal club · 19 Feb 2025 · 0 likes I read post #131 twice before replying, because I had assumed the opposite. The most useful reply I ever got about SURPASS-2 was a request to state my units. It sounds…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #85 · Sourcing › Regulatory · 15 Feb 2025 · 12 likes A label change is a regulatory event with a date and a document. Citing the document is what makes a claim about labelling checkable. None of the above is medical…
-
Transit times by route, from a logged dataset — the long version Replied, post #51 · Sourcing › Logistics · 20 Jan 2025 · 25 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. The confident version of this sentence would be wrong,…
-
Second pass at: Regression to the mean in progress reports Replied, post #26 · Research Methods › Statistics · 16 Jan 2025 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Fixed versus detachable needles: the trade-offs Replied, post #67 · Devices › Syringes & needles · 23 Dec 2024 · 0 likes Fixed versus detachable needles has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #42 · Safety › Adverse events · 23 Dec 2024 · 8 likes The most useful reply I ever got about Persistent vomiting was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #66 · Practice › Side effects · 12 Dec 2024 · 3 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #109 · Clinical › Prescriber conversations · 27 Nov 2024 · 0 likes Write the questions down in advance and put the most important one first. Appointments end and the order is what decides which questions get answered. Adding this to…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #19 · Nutrition & Training › Protein & intake · 24 Nov 2024 · 0 likes Renal considerations around higher protein intake apply to people with existing renal impairment and are frequently generalised beyond that population. I am reporting…
-
Transporting a vial for a weekend away Replied, post #39 · Practice › Storage & stability · 7 Nov 2024 · 7 likes Worth separating two things that post #37 runs together. Since transporting a vial keeps coming up, it should probably be a maintained page rather than a recurring…
-
A page that has drifted out of date and needs a maintainer Replied, post #26 · Documentation › Wiki requests · 7 Nov 2024 · 27 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change. A guess, clearly labelled as one.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #88 · Practice › Dosing & titration · 22 Oct 2024 · 15 likes Confirming post #87 from a second method, which matters more than confirming it from a second person. There is no published evidence about slower escalation because…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #4 · Compounds › Tirzepatide · 20 Oct 2024 · 19 likes The opening post is the version of this I will quote in future. One addition. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #71 · Access › Shortages · 11 Oct 2024 · 19 likes Right, and stated more narrowly than I would have dared to state it.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #140 · Nutrition & Training › Hydration & electrolytes · 7 Oct 2024 · 19 likes Supplementing without measuring is the default approach described here and it carries its own risks, particularly for potassium.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #63 · Practice › Dosing & titration · 14 Sep 2024 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed four-week escalation interval, as opposed to read about it? The thread is long and I…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #20 · Compounds › Oral incretins · 13 Sep 2024 · 2 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #53 · Analytics › COA interpretation · 13 Sep 2024 · 11 likes Confirming post #50 from a second method, which matters more than confirming it from a second person. When a document puts the specification in the result column, it…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #12 · Compounds › Tirzepatide · 8 Sep 2024 · 2 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #9 · Analytics › Method validation · 6 Sep 2024 · 27 likes Everything in post #5 holds. The case it does not cover is the one I have. Relative retention time has been discussed here with more heat than it deserves, mostly…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #29 · Devices › Syringes & needles · 2 Sep 2024 · 24 likes I would keep Dead volume across syringe and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and…
-
When to suspect the method rather than the sample Replied, post #5 · Analytics › Method validation · 22 Aug 2024 · 19 likes Understood, and I withdraw the assumption I opened with.
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #3 · Compounds › Secretagogues & GH axis · 31 Jul 2024 · 0 likes Growth hormone secretagogues act on the ghrelin receptor or on the growth hormone releasing hormone receptor rather than supplying growth hormone, which is the…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #27 · Clinical › Prescriber conversations · 27 Jul 2024 · 26 likes Following this. I have the same question and no better information than the first post.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #109 · Practice › Dosing & titration · 10 Jul 2024 · 19 likes I had written a reply contradicting post #105 and deleted it. Here is what survived. If symptoms reset at each step, that is the expected pattern rather than a sign…
-
How this community labels and discusses unrefereed work Replied, post #35 · Evidence › Preprints · 23 Jun 2024 · 5 likes A preprint that has been up for two years without appearing in a journal is telling you something, and it is not necessarily that the work is bad. Adding it in case it…
-
Assessing a warm arrival: the decision process — one year on Replied, post #38 · Sourcing › Logistics · 29 May 2024 · 13 likes I read post #34 twice before replying, because I had assumed the opposite. The claim about Assessing a warm arrival upthread is stronger than its source supports. I…